Institutional Ownership
Albireo Pharma Inc
CUSIP 01345P106COMMON STOCKBDQMQ1 2026
13D / 13G Filings
36
Schedule 13D/13G on record
Beneficial Filers
13
Distinct reporting persons
Largest Stake
13.4%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
36 filings · latest Feb 14, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 14, 2024 | Deep Track Capital, LP | 13G/A | — | — | SEC |
| 2 | Apr 10, 2023 | Federated Hermes, Inc. | 13G/A | — | — | SEC |
| 3 | Mar 8, 2023 | Blackrock Inc. | 13G/A | 2.4% | 506.4K | SEC |
| 4 | Mar 2, 2023 | Ics Opportunities, Ltd. | 13G | 4.3% | 893.9K | SEC |
| 5 | Feb 27, 2023 | Beryl Capital Management LLC | 13G | 7.1% | 1.48M | SEC |
| 6 | Feb 24, 2023 | Carlson Capital L P | 13G | 1.0% | 178.1K | SEC |
| 7 | Feb 14, 2023 | Tang Capital Partners LP | 13G/A | 2.0% | 412.0K | SEC |
| 8 | Feb 14, 2023 | Perceptive Advisors LLC | 13G/A | 8.5% | 1.76M | SEC |
| 9 | Feb 14, 2023 | Deep Track Capital, LP | 13G/A | 8.2% | 1.70M | SEC |
| 10 | Feb 1, 2023 | Federated Hermes, Inc. | 13G/A | 9.4% | 1.96M | SEC |
26 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Albireo Pharma Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Huntington National Bank | 1 | $44 |